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Non-technical Summary 
The recent decade has shown a surge of firms globalising their innovation activities. This 
means that these firms have enlarged the number of countries where they perform R&D 
projects. Hence, for more and more firms R&D is no longer a purely domestic activity. A 
major motive underlying the decision to shift corporate R&D activities abroad is that firms 
seek to increase their chances to participate in international knowledge sharing. Absorbing 
knowledge from abroad is aimed at enhancing firms’ innovativeness and consequently their 
competitiveness. 
This paper aims at analysing whether a firm’s innovation performance is enhanced by 
globalised R&D. In order to evaluate the benefits of a strategy that disperses R&D across 
foreign countries, we compare firms which have globalised their R&D activities with firms 
performing R&D only in their home country and with firms that are engaged in no R&D 
activities at all. One main novelty of our research is that we furthermore distinguish between 
different degrees of R&D internationalisation, that is, the number of foreign countries in 
which a firm has R&D laboratories. This allows us to shed light on the two competing 
hypotheses by Malecki (1980) and Von Hippel (1988) whether stronger dispersed 
international R&D activities hamper or stimulate firms’ innovation. Compared to previous 
research that is based on patents, we use two different well-established innovation output 
indicators to shed light on the effects of domestic and foreign R&D: first, the introduction of 
new products and second their market success which is measured as the sales growth rate due 
to these innovations. We additionally examine whether the effects of international R&D vary 
with different degrees of product novelty (firm and market novelties).  
The study is based on a large data set of about 2100 firms surveyed in the Mannheim 
Innovation Panel (MIP). The MIP represents the German part of the European-wide 
harmonised Community Innovation Surveys (CIS).  
Based on econometric analyses, we confirm that firms with both domestic R&D and foreign 
R&D activities are more likely to launch new products than firms with home-based R&D only 
or non-R&D performers. This can be observed for both kinds of product innovations: market 
novelties and firm novelties. Regarding the innovation success, however, the results are not as 
clear-cut. Given the introduction of a firm novelty, firms with international R&D centres are 
also more successful than non-R&D performers and tend to be more successful than firms 
conducting solely domestic R&D. On the contrary, the findings reveal that the location of 
 R&D does not matter for the success of market novelties once the market novelty has been 
launched to the market. 
By comparing different degrees of R&D internationalisation, the study points out that firms 
with medium decentralised foreign R&D activities (in 2-3 countries) have a significantly 
higher likelihood to develop both market and firm novelties compared to firms with 
centralised foreign R&D in only one foreign subsidiary. A more decentralised foreign R&D 
organization does not exert an additional stimulating effect on the propensity to develop 
market novelties. On the other hand, it further increases the likelihood to develop firm 
novelties.  
The results further elucidates that firms with medium decentralised R&D abroad achieve a 
higher sales growth with new products than firms which conduct R&D at home only or than 
firms with highly decentralised foreign R&D activities. Again, the higher sales growth rates 
are mainly driven by firm novelties, not by market novelties. That is, given the introduction of 
a market novelty, the degree of decentralisation of international R&D activities does not play 
a role for innovation success.  
Finally, another salient finding that originates from this analysis is that German firms that 
have expanded their R&D only to one foreign country do not outperform firms with domestic 
R&D.  
 Das Wichtigste in Kürze 
Mit dem Ziel ihre Innovationskraft und ihre Wettbewerbsfähigkeit zu steigern, haben 
Unternehmen in den letzten Jahren zunehmend ihre Forschungs- und Entwicklungstätigkeiten 
(FuE) internationalisiert.  
Diese Studie untersucht, ob und inwiefern internationale FuE-Tätigkeiten tatsächlich zu einer 
besseren Innovationsleistung der Unternehmen führen. Um die Strategie der 
Internationalisierung von FuE-Aktivitäten zu beurteilen, wird die Innovationsperformance 
von Unternehmen, die sowohl national als auch international FuE-Projekte durchführen 
verglichen mit denjenigen, die nur in ihrem Heimatland FuE tätigen und mit denjenigen, die 
keinerlei FuE-Tätigkeiten aufweisen. Unsere Studie unterscheidet sich von der bisherigen 
Forschung insbesondere in zwei Aspekten: Erstens unterscheiden wir Unternehmen nach dem 
Grad der Internationalisierung ihrer ausländischen FuE-Tätigkeiten. Dies erlaubt uns die 
Hypothese zu untersuchen, ob eine zunehmende Dezentralisierung von FuE den 
Innovationserfolg auf Grund des besseren Zugangs zu Wissensquellen erhöht oder auf Grund 
der zunehmenden Koordinierungskosten beeinträchtigt. Zweitens nutzen wir nicht wie 
bisherige Studien Patente als Erfolgsindikator, sondern evaluieren die Ergebnisse dieser 
unterschiedlichen Innovationsstrategien an Hand zweier marktbasierter Indikatoren. Dabei 
handelt es sich zum einen um die Einführung neuer Produkte und zum anderen um das 
Umsatzwachstum, das durch neue Produkte generiert wird. Bei neuen Produkten wird jeweils 
nach dem Grad der Neuigkeit unterschieden zwischen neuen Firmen- und Marktneuheiten. 
Die Studie basiert auf den Daten von ca. 2100 Unternehmen, die im Rahmen des Mannheimer 
Innovationspanels (MIP) erhoben wurden. Das MIP stellt den deutschen Beitrag der 
europaweit harmonisierten Innovationserhebungen (CIS) dar.  
Die Ergebnisse der ökonometrischen Analyse zeigen, dass Unternehmen, die sowohl im In- 
als auch im Ausland FuE betreiben, eine größere Wahrscheinlichkeit haben neue Produkte 
einzuführen als Unternehmen, die nur in Deutschland FuE betreiben oder die gar keine FuE 
durchführen. Dies gilt sowohl für Produkte, die neu für den Markt insgesamt sind als auch für 
solche, die nur eine Neuigkeit für das Unternehmen darstellen. Die Ergebnisse bezüglich des 
Innovationserfolgs sind dagegen nicht eindeutig. Unter der Voraussetzung, dass ein 
Unternehmen eine Firmenneuheit eingeführt hat, weisen Unternehmen mit internationaler 
FuE-Aktivität auch ein höheres Umsatzwachstum mit diesen neuen Produkten auf als andere 
Unternehmen. Das gleiche Erfolgsmuster lässt sich jedoch für Marktneuheiten nicht 
beobachten. Wenn es einem Unternehmen gelungen ist, eine Marktneuheit einzuführen, dann 
 spielt der Ort, wo diese Marktneuheit entwickelt wurde, letztlich keine Rolle für den 
Innovationserfolg mit diesen Produkten. 
Differenziert man nach dem Grad der Internationalisierung, dann zeigt sich, dass 
Unternehmen mit ausländischen FuE-Standorten in einer moderaten Anzahl an Ländern (2-3 
Länder) eine signifikant höhere Wahrscheinlichkeit haben, Markt- und Firmenneuheiten 
einzuführen als Unternehmen, die nur in einem ausländischen Standort FuE-Aktivitäten 
betreiben. Eine darüber hinaus gehende Dezentralisierung der FuE-Aktivitäten wirkt zwar 
noch positiv auf die Einführung von Firmenneuheiten, hat jedoch keinen zusätzlich 
stimulierenden Effekt auf die Einführung von Marktneuheiten.  
Die Ergebnisse zeigen darüber hinaus, dass Unternehmen mit einem mittleren 
Internationalisierungsgrad ein signifikant höheres Umsatzwachstum mit neuen Produkten 
erzielen. Dieses lässt sich erneut auf Firmen-, aber nicht auf Marktneuheiten zurückführen. 
D.h. gegeben die Einführung einer Marktneuheit, spielt der Grad der FuE-
Internationalisierung des Unternehmens, keine Rolle für den Innovationserfolg.  
Ein weiteres markantes Ergebnis dieser Studie ist, dass Unternehmen, die ihre ausländischen 
FuE-Aktivitäten bislang auf ein Land konzentriert haben, keine signifikant bessere 
Innovationsperformance aufweisen als Untenehmen, die nur im Inland FuE durchführen.  
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Abstract 
Recent years have shown a surge of firms globalising their innovation activities in order to 
gain from international knowledge. This paper evaluates this strategy by investigating 
whether firms with international R&D are more innovative than firms doing R&D only in 
their home country. One main novelty is that we shed light on two competing hypotheses 
whether stronger dispersed international R&D activities hamper or stimulate innovation. 
Second, we employ two well-established market-based indicators for innovation (introduction 
of and sales growth rates due to new products) instead of looking at inventions (patents). 
Using German CIS data for about 2100 firms, the econometric results show that firms with 
international R&D are more likely to launch new products (firm and market novelties) than 
firms with home-based R&D only. They are also more successful in terms of higher sales 
growth with firm novelties. However, given the introduction of a market novelty, the location 
of R&D doesn’t matter for the sales growth with market novelties. The results concerning the 
degree of R&D internationalisation are mixed: The likelihood of introducing firm novelties 
increases with a stronger dispersion of foreign R&D activities (for market novelties only up to 
a specific point). The relationship between degree of R&D internationalisation and innovation 
success turns out to be inverse u-shaped. 
 
 
Keywords: R&D, Internationalisation, Innovation performance, Decentralisation 
JEL-Codes: O32, F23 
 
 
Acknowledgements  
We are grateful to Georg Licht, Christian Rammer, Jürgen Weigand and participants at the INIR 
Workshop (Leuven, 2008), the Asigo Conference (Nuremberg, 2009), the Micro Evidence on 
Innovation and Development (MEIDE) Conference (Tartu, 2010), the International Industrial 
Organization Conference (Vancouver, 2010), the Annual Meeting of the Academy of International 
Business (AIB; Rio de Janeiro, 2010), the European Association for Research in Industrial Economics 
(EARIE) Conference (Istanbul, 2010) and seminars at ZEW (Mannheim, 2009) and WHU (Vallendar, 
2010) for helpful comments and suggestions on previous versions. All remaining errors are ours. 
1 
1 Introduction  
Firms’ competitiveness depends to a great extent on their innovativeness. Due to the 
increasing technological complexity of products and processes and the speeding up of 
technological progress, firms have to source knowledge outside their boundaries in order to 
complement internal knowledge. This includes the use of globally available resources to 
foster their innovation outcomes (Kotabe, 1990). In order to do so, firms may pursue different 
strategies. The two most prominent strategies are to cooperate with international partners or to 
establish own research and development (R&D) laboratories abroad. Fascinatingly, the recent 
decade has shown that corporations increasingly globalise their R&D and innovation 
activities by setting up own foreign R&D departments (UNCTAD, 2005). This phenomenon 
can be observed for both large multinational firms (MNEs) and international SMEs. In 
Germany for instance, about 3% of – mainly medium-sized – innovative firms without foreign 
R&D activity in 2005 planned to start it in the subsequent two years 2006/2007 (Rammer and 
Schmiele, 2008).  
The international business literature stresses that firms pursue two main motives by 
performing their R&D activities abroad (Granstrand et al., 1993, Von Zedtwitz and 
Gassmann, 2002, Kuemmerle, 1997). On the one hand, firms want to adapt their existing 
technologies to local demand and manufacturing conditions (exploitation strategy). On the 
other hand, by setting up foreign R&D subsidiaries firms seek to get access to local science 
and technology resources which enable them to absorb and integrate knowledge from abroad 
into their innovation process (home-base augmenting strategy). It has been emphasised that an 
effective innovation strategy needs to balance the exploitation of existing knowledge with 
non-local knowledge exploration (Levinthal and March, 1993). It has further been proven that 
putting existing pieces of knowledge together often leads to innovations (Grant, 1996; Arora 
and Gambardella, 1990; Cohen and Malerba, 2001). In this vein, the internationalisation of 
innovation activities may lead to the combination of existing knowledge from the firm’s 
knowledge stock with foreign knowledge contributed by foreign local staff and spillovers 
from the firm’s foreign business environment such as cooperating firms, competitors, 
customers, suppliers and scientific institutions. Given that knowledge spillovers are stronger 
within countries than across countries (Jaffe et al., 1993; Branstetter, 2001), firms that 
perform R&D activities only in their home country are less likely to have access to foreign 
knowledge. Learning-by-exporting has been considered one alternative of how firms could 
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benefit from foreign countries’ expertise by engaging in local markets and interacting with 
customers (Clerides et al., 1998; Bernard and Jensen, 1999). However, it is pointed out that 
knowledge often cannot overcome national boundaries when it is not codified (implicitly) and 
embedded in routines and thus hard to transfer (Kogut, 1991; Kogut and Zander, 1992).  
The potential knowledge gains from foreign R&D stand facing potential losses. They may 
arise due to intra-firm knowledge losses, intra-firm coordination costs of research or foregone 
economies of scale in conducting research. Despite the trend to internationalise R&D, the 
empirical evidence about the effectiveness of foreign R&D in terms of innovation output is 
rather scarce and limited to patents. But patent-based indicators have been heavily criticised 
as being a rather poor yardstick for innovative output (see, e.g., Scherer, 1965; Griliches, 
1990). In this paper we address the question whether international R&D is conducive to a 
firm’s innovation performance.  
Our research aims at extending the existing literature in three ways. First, we use two 
alternative well-established market-based innovation performance measures. We provide 
evidence of how potential gains from foreign R&D activities influence the introduction of 
new products (“innovation outcome”) and whether firms with foreign R&D achieve a higher 
sales growth with innovative products (“innovation success”). Product innovations can be 
either new to the firm only (firm novelty) or to the market as a whole (market novelty), i.e. 
they greatly vary according to their degree of novelty. We suppose that foreign R&D is more 
crucial for developing market novelties and thus secondly examine whether the effects vary 
with the degree of product novelty. Since firms are expanding their number of international 
research locations, we finally investigate the effect of a greater decentralisation of foreign 
R&D locations on firms’ innovation performance.  
To answer our research question, we estimate knowledge production functions (Pakes and 
Griliches, 1984) by employing the two-step selection model proposed by Heckman (1979). 
The empirical analysis draws upon a sample of about 2100 German firms collected within the 
Community Innovation Surveys (CIS). In contrast to previous studies that mainly compare the 
contribution of foreign and home-based R&D activities for firms with globalised R&D 
activities, our data set allows us to liken firms with globalised R&D to firms performing R&D 
only at their home country or doing no R&D activities at all. The potential added value of 
foreign R&D to domestic R&D in comparison with only domestic R&D activities in terms of 
innovation performance is interesting both to scholars and managers. 
To summarise our main results: We find that firms with both domestic and foreign R&D 
activities are more likely to launch new products (both firm and market novelties) than firms 
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with home-based R&D only. Given the introduction of a new product they do likewise 
achieve a significantly higher sales growth due to this innovation than firms with home-based 
R&D only. This higher innovation success can be traced back to firm novelties. No 
differences in innovation success, however, could be found for market novelties. The degree 
of R&D internationalisation has an inverse u-shaped effect on both innovation performance 
measures. A moderate number of R&D locations abroad exert the strongest influence on 
innovation outcome with new products, market and firm novelties. Further, sales growth due 
to product innovations and firm novelties also peaks with a moderate number of R&D 
locations abroad. 
This paper continues in the following outline: section 2 presents related literature and relevant 
theoretical concepts which lead to the development of hypotheses. Section 3 explores the 
dataset and the empirical methods which are employed to test the hypotheses. Section 4 sets 
forth the results of the econometric analysis, and section 5 concludes with a discussion of the 
retrieved results and management recommendations. 
2 Internationalisation of R&D Activities – What Do We Know so 
Far? 
2.1 Potential Benefits of International R&D 
Multinational Enterprises (MNE) are said to be an important driver of globalization by 
increasing the interdependency and relatedness of geographically dispersed actors (Archibugi 
and Immarino, 2002). The internationalisation of internal R&D activities has followed the 
internationalisation of production and other market-related business processes. Though R&D 
still shows the least degree of internationalisation of all business processes, it is an increasing 
phenomenon (see UNCTAD, 2005). The UNCTAD (2005) report shows that about 40% of 
the Western European firms have international R&D expenditures in comparison to 24% of 
the North American MNEs and 15% of the Japanese multinationals. The industries which 
show the highest degree of international R&D spending are chemicals, pharmaceuticals, 
electronics and automotive.  
The motivations of firms to internationalise their R&D have been distinguished into market 
seeking, technology seeking and efficiency seeking purposes. However, it is unlikely that 
firms are driven only by one but rather by all three motivations (DeMeyer, 1993). 
Furthermore, the objectives of R&D labs abroad have been changing over time towards 
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knowledge sourcing and development tasks (Frost, 2001; Hakanson and Nobel, 1993; 
Wortmann, 1990). The internationalisation of R&D enables firms to both widen and deepen 
their technological scope (Pearce and Papanastassiou, 1996) due to improved technical 
learning which is fostered by international R&D activities (DeMeyer, 1993).  
The resourced-based theory of the firm provides a framework to explain the differences in 
firms’ strategic decisions, performance and competitive advantage (Grant, 1996; Liebeskind, 
1996) Firms are seen as bundles of resources and capabilities that act as knowledge-
integrating institutions and develop and deploy the resource base (Grant, 1996). Firms with 
superior resources will generate rents (Peteraf, 1993). The knowledge-based view which has 
evolved from the resource-based theory emphasises knowledge as one of the most valuable 
resources. The sourcing of global knowledge would allow firms to gather additional and 
distinct knowledge relative to rivals and inhibits the chance to build an idiosyncratic 
knowledge base which can become a competitive advantage (Peteraf, 1993). This mind-set 
leads to the assumption that numerous pools of knowledge are more beneficial to a firm’s 
innovativeness than a few sources. For developing new products, however, it is ultimately 
essential to apply the knowledge which creates a competitive advantage in case of a 
successful innovation (Liebeskind, 1996; Grant, 1996). The knowledge-based view of the 
firm thus implies that the foreign knowledge will increase firms’ innovativeness and market 
success with innovations when they possess abilities necessary to utilise their knowledge 
base. In this regard, the corporate knowledge base also provides the foundation to decide 
which and how knowledge is applied in actual and future periods (Ndofor and Levitas, 2004).  
2.2 Moderating Factors of Firms’ Benefits of International R&D   
The potential benefits of international R&D activities are moderated by a number of factors 
that can hamper the outcome of international research activities. The improvement of 
innovation performance can only be as strong as the international R&D performing firms 
realise and use the chances of these ventures. Thus, it is important for firms to pursue an 
appropriate strategy to capture the resources abroad which are beneficial to them and to avoid 
losses.  
First, the roles and tasks which are assigned to the innovating subsidiaries abroad affect their 
importance for the firms’ innovation output (Iwasa and Odagiri, 2004). The mandates of 
subsidiaries abroad differ by their level of R&D orientation and their focus on production 
support. Some R&D labs abroad have the task to absorb new knowledge and to develop new 
products. They act as ‘knowledge augmenting’ units (Kuemmerle, 1997) or ‘global creators’ 
(Nobel and Birkinshaw, 1998). Other R&D centres abroad are characterised as ‘local or 
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global adaptors’ (Nobel and Birkinshaw, 1998), ‘home base exploiting’ (Kuemmerle, 1997) 
units or ‘support laboratories’ (Pearce, 1989). Their work description comprises the support of 
local production, the assimilation of market knowledge and the application to customers’ 
satisfaction (Pearce and Papanastassiou, 1996). According to their different mandates, R&D 
centres abroad are likely to generate distinct degrees of quality and quantity of knowledge and 
skills. While some subsidiaries can contribute to the development of new products, the 
adaptation of existing products is aimed at enhancing the sales of innovative products on 
foreign markets.  
The type of R&D and as a result the degree of novelty of the innovation output is also 
determined by the international R&D organization (Chiesa, 1996), in particular by the degree 
of decentralisation. A centralised R&D organization conducts all the necessary work to 
develop new products in one location (Malecki, 1980) which is mostly in the firm’s home 
country. In decentralised R&D structures, research is carried out within divisions or business 
units (Argyres and Silverman, 2004). The role of decentralisation for innovation performance 
is ambiguous. Some scholars have argued that centralization of R&D facilities is the better 
R&D organization for research purposes since economies of scale and scope can be realised 
(Malecki, 1980; Von Zedtwitz et al., 2004). The international decentralisation of a firm’s 
R&D organization demands not only the management of corporate innovation efforts between 
the headquarter and subsidiaries but also across country borders. This involves the risk that 
knowledge is getting lost when it is transferred between R&D units (Szulanski 1996) or that 
innovation projects are duplicated in different R&D units (Gassman and Von Zedtwitz 1999). 
The increase in transactions due to the internationalisation is likely to drive the costs as 
proposed by the transaction cost theory (Coase, 1937; Williamson, 1985). Opponents argue 
that R&D decentralisation reduces managerial opportunism at a single R&D centre and 
empowers divisions which are closer to markets and specific demands (Von Hippel, 1988; 
Williamson, 1985).  
Another linchpin is the degree of international R&D decentralisation and the way of 
transferring and integrating international subsidiary knowledge into the corporate innovation 
process. The management and integration of international R&D centres are an important topic 
in the international business literature (Gassmann and Von Zedtwitz, 1999; Von Zedtwitz et 
al., 2004; Edler et al., 2002; Hemmert, 2003/04). It has been argued that the usage of the 
potential global know-how does not depend on the presence of R&D labs in many parts of the 
world per se but more importantly on the internal firm mechanisms to integrate knowledge 
across R&D organizations (Singh, 2008). Leveraging the capabilities and resources of 
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subsidiaries across divisions and locations has been put forward to be essential for the global 
success of firms (Bartlett and Ghoshal, 1989; Birkinshaw et al., 1998; Frost et al., 2002; 
Nobel and Birkinshaw, 1998). In our research framework, special attention has to be paid to 
knowledge flows within MNEs. The integration of the foreign R&D labs is on the one hand 
fostered by personnel contacts and exchanges between home and overseas R&D centres. It is 
likewise important for the transfer of locally developed knowledge to the domestic 
headquarter (Hakanson and Nobel, 2001; Björkmann et al., 2004). On the other hand, the 
integration of the outcomes of R&D performed abroad requires a certain stage of R&D 
activeness of the recipient firm in the home country. Firms should carry out R&D 
continuously to keep up with technological developments (Tilton, 1971) and hereby develop 
their ability to identify and absorb new information from overseas R&D subsidiaries (Cohen 
and Levinthal, 1989, 1990). These so-called absorptive capabilities of the receiving firm 
stimulate knowledge flows (Minbaeva et al, 2003) or act as a barrier to MNEs’ knowledge 
flows if they lack these capabilities (Szulanski, 1996).  
A firm that sources knowledge from the host country is most likely to benefit from these 
activities if the foreign knowledge complements existing knowledge in its R&D labs in the 
home country. The complementarity concept generally means that one activity pays off more 
if the other activity is also carried out (Milgrom and Roberts, 1995; Schmiedeberg, 2008). 
Therefore, domestic and foreign R&D act as complements if conducted together they increase 
the innovation performance more than one R&D activity alone. A variety of 
complementarities in R&D activities have been proved to positively influence innovation 
success: Internal R&D has been found to be complementary to contracted R&D 
(Schmiedeberg, 2008), external technology acquisition (Cassiman and Veugelers, 2006) and 
R&D cooperation for different industries and partners (Schmiedeberg, 2008; Cassiman and 
Veugelers, 2002, 2005; Schmidt, 2005; Arora and Gambardella, 1990). Some of the 
advantages apply only to truly external firm innovation partners such as risk and cost sharing 
(Love and Roper, 2004) and do not count for international corporate research centres. 
Notwithstanding, domestic and foreign R&D may generate synergy effects since different 
locations may imply access to additional sources of knowledge. 
2.3 The Innovation Output of Firms with International R&D 
The existing literature provides only scarce evidence whether international R&D is beneficial 
to firms’ innovation performance. Existing studies can be distinguished whether they focus on 
the innovative performance of foreign R&D subsidiaries or on the effect on innovations 
developed by the headquarter. The to-date studies mostly use patent data to analyze the 
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impact of foreign knowledge sources on firms’ innovations. Following this strategy, Iwasa 
and Odagiri (2004) have examined the contribution of R&D abroad on the firms’ invention 
activity at home and abroad for a sample of 137 Japanese MNEs. They find that innovative 
(not adaptive) R&D which is carried out abroad in the US and EU exert a positive impact on 
the number of a firm’s inventions in Japan, as measured by the number of granted patents. 
Their results thus confirm the technology sourcing activities of subsidiaries abroad. Using a 
panel study of 65 Japanese pharmaceutical firms, Penner-Hahn and Shaver (2005) have 
examined the role of foreign R&D on the number of patents as performance measure. They 
confirm that international R&D activities exert a positive effect on patenting. Phene and 
Almeida (2008) have investigated the determinants of subsidiary innovation. They provide 
evidence that knowledge from host country firms positively affects scale (number of patents) 
and quality (number of citation received) of subsidiary innovation. On the contrary, 
knowledge assimilated from MNE headquarters and other subsidiaries play no significant role 
for subsidiary innovation. Frost (2001) studied the geographic sources of foreign subsidiaries’ 
innovation. He distinguishes firms’ innovation activities abroad into the exploitation of 
existing firm knowledge and exploring local knowledge sources abroad. His findings suggest 
that foreign subsidiaries’ patents rather cite knowledge sources from those locations that 
possess the strongest expertise and technological advantage. Foreign subsidiaries’ patents are 
therefore likely to be based on host country knowledge when it is technological advanced in 
that relevant field and if the foreign subsidiary is of larger scale. 
Despite the controversial discussion about the effect of an increasing degree of international 
R&D decentralisation, the international business literature still lacks empirical evidence. So 
far, the impact of R&D organization on innovative outcome has been analysed for the number 
of national R&D locations within Finland (Leiponen and Helfat, 2010) and the US (Argyres 
and Silverman, 2004). Leiponen and Helfat (2010) find that R&D decentralisation fosters the 
extent and positive impact (e.g. reduction of costs, opening of new markets, fulfilling standard 
or regulations) of innovation outcomes. Argyres and Silverman (2004) explore the link 
between firms’ R&D organization and the importance of innovations produced for a small 
sample of 71 US firms. To measure the importance of innovations, they employed distinct 
indicators based on patent citations. In contrast to Leiponen and Helfat (2010), their findings 
suggest that firms with centralised R&D organizations generate innovations with greater 
technological impact (number of citations) and they impact upon a broader range of 
technological areas. However, the effect was found to be non-linear. That is, firms with 
strongly decentralised R&D exhibit a greater innovation impact than firms with slightly 
decentralised R&D. In a related study, Singh (2008) has evaluated the effect of 
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geographically dispersed – but not necessarily international – R&D activities on the quality of 
innovation performance.1 Employing the number of patent citations as performance indicator 
he finds on average a significantly negative influence of the geographic spread of R&D 
activities on the innovation value. This result indicates that potential gains from access to 
diverse knowledge from different locations are offset by difficulties in managing and 
integrating knowledge across dispersed R&D units. Firms pursuing cross-regional knowledge 
integration strategies2 benefit more from dispersed R&D though the overall effect remains 
negative. Notwithstanding, there is no evidence so far whether these results also hold for 
international R&D decentralisation and our research is aimed at filling this gap. 
Furthermore, all above-mentioned studies are based on patent data. As it has been argued 
before, patents might not always be the appropriate way to capture the innovation success of 
R&D activities. Patents prove the result of inventive activities and display the location of 
inventors. However, not all patented inventions result in innovations and not all inventions 
and innovations are patented (Griliches, 1990; Jaffe and Trajtenberg, 2002). Therefore, 
patents cover only a threshold of the results from innovation activities abroad (Levin et al., 
1987; Arundel and Kabla, 1998). Some underlying reasons are time and costs which are 
involved in the patent application process, as well as the aspect of knowledge disclosure by 
patents and the fact that only new inventions can be patented, innovations new to the firm are 
not patentable. In a recent study on a related topic, Criscuolo et al. (2010) have employed 
both patent data and firm level innovation data to investigate the effect of global engagement 
on innovation performance. They find that globally engaged firms (per definition 
multinational parent firms and multinational affiliates) applied for more patents, have a higher 
likelihood of introducing innovations and achieve a higher share of sales with innovations. 
These results add a more international perspective to the existing innovation performance 
literature. However, this study merely analyses how firm status, measured by indicator 
variables for a multinational parent, a multinational affiliate, a local exporting firm and a local 
non-exporting firm, affects innovation performance. The effect of both domestic and foreign 
research and development activities on innovation performance remains unobserved. 
Therefore our paper aims to contribute firm-level evidence about international R&D activities 
and their effect on innovation outcome and innovation success.  
                                                 
1 The spread is measured as the average geographic distance between the address of the first investors in any two 
patent pairs of the firm.  
2 Cross-regional knowledge integration is measured along three dimensions: inventors with regional ties, 
regional mobility of inventors and knowledge sourcing from other locations within the firm. 
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 2.4 Hypotheses  
In order to investigate the relationship between international R&D activities and innovation 
performance, we test six hypotheses. Following the rationale of the knowledge-based view, a 
larger number of R&D locations give firms the opportunity to interact with a greater number 
of international actors and a wider range of knowledge sources. Accordingly, firms’ 
international R&D activities represent an advantage by having multiple contacts with foreign 
knowledge sources. The access to a larger knowledge pool should result in a better innovation 
outcome (H1) and innovation success (H2):  
H1:  Firms with international R&D activities are more innovative than firms that undertake 
R&D solely in their home country. 
H2: Firms with international R&D activities achieve a higher innovation success than 
firms that only have domestic R&D capacities. 
Section 2.2 has elaborated on some moderating factors that affect benefits. The second set of 
hypotheses is devoted to the role of the degree of R&D internationalisation and its impact on 
innovation. The literature provides two competing hypotheses how the degree of 
internationalisation of R&D dispersion may affect innovation outcome and innovation 
success. Therefore we define hypotheses H3a and H4a based on the arguments stemming 
from the knowledge-based view and the expected positive effects of a decentralised R&D 
organisation raised by Von Hippel (1988): 
H3a: The degree of R&D internationalisation has a positive influence on the likelihood of 
introducing innovations (innovation outcome). 
H4a: The degree of R&D internationalisation has a positive influence on firms’ innovation 
success. 
Following the line of reasoning that increased international R&D decentralisation implies the 
loss of economies of scale and scope, the higher likelihood of redundant innovation projects 
and higher transaction costs, we formulate hypotheses H3b and H4b which state that these 
costs outweigh the gains due to better access to foreign knowledge: 
H3b:  The degree of R&D internationalisation has a negative influence on the likelihood of 
introducing innovations (innovation outcome). 
H4b: The degree of R&D internationalisation has a negative influence on firms’ innovation 
success.  
A rejection of hypothesis H3a would lead to the conclusion that the costs outweigh the 
benefits of international R&D activities and thus speak in favour of hypothesis H3b. Due to 
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lack of data and similar to Singh (2008), we cannot test hypotheses about the other 
moderating factors, i.e. about the effect of subsidiaries’ mandates and internal organisational 
mechanisms to transfer knowledge across different R&D units within the firm efficiently. 
Instead we will draw indirect inference on these matters based on our results. 
3 Empirical Analysis  
3.1 Data Set   
To test our hypotheses, we employ data from the Mannheim Innovation Panel (MIP). The 
MIP is an annual innovation survey conducted by the Centre for European Economic 
Research (ZEW), the Fraunhofer Institute for Systems and Innovation Research (ISI) and the 
Institute for Applied Social Sciences (infas) on behalf of the German Federal Ministry of 
Education and Research (BMBF). The survey methodology and definitions of innovation 
indicators are based on the Oslo Manual (see OECD and Eurostat 2005), thereby yielding 
internationally comparable data on innovation activities of German enterprises. The MIP is 
the German contribution to the Europe-wide harmonised Community Innovation Surveys 
(CIS) which take place every 4 year and since 2005 every second year. The MIP survey 
targets legally independent firms with headquarters located in Germany and with at least five 
employees in manufacturing, mining, energy and in selected service sectors. The survey is 
drawn as a stratified random sample and is representative of the corresponding target 
population. 
The CIS provides rich information on firms' innovation behavior such as the introduction of 
product and process innovation, innovation expenditure, R&D engagement, share of sales 
with new products, information sources, hampering factors and general firm information such 
as sales, employment, exports, type of ownership and so on. The data has increasingly been 
exploited in empirical research to study a variety of innovation-related questions (see e.g. 
Cassiman and Veugelers, 2006; Criscuolo et al., 2010 and the survey by Mairesse and 
Mohnen, 2010). Usually, the MIP goes beyond the extent of the core CIS surveys and poses 
additional questions on innovation-related topics. The 2006 survey additionally collects data 
about foreign innovation activities. Firms were asked whether they conduct foreign 
innovation activities in 2005 and if so what kind of activity they perform abroad (R&D, 
implementation of new processes, conception/design/construction of new products, 
manufacturing of new products or merely sales of new products). For each type of activity 
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firms were furthermore requested to state in a free text field in which countries they 
predominantly perform them.  
Its design as a panel data set presents a main virtue of the MIP. Unfortunately, information on 
international R&D activities is only available in one wave. However, by merging different 
waves, the panel structure allows us to analyze the effect of R&D activities abroad on future 
innovation performance. More precisely, we merge the 2006 survey with the latest available 
2009 survey. This creates a time lag of 3 years between existing corporate R&D activities 
abroad in 2005 (2006 survey) and the measurement of innovation performance in the period 
2006-2008 (2009 survey). Since empirical evidence has pointed towards the fact that firms 
tend to carry out rather applied R&D at foreign locations, the observed time lag of up to three 
years between innovation efforts and observed performance seems to be adequate. Moreover, 
this approach reduces potential endogeneity problems between the location of R&D activities 
and innovation output which usually arise in cross-sectional analyses. Endogeneity might 
occur because the most innovative firms may have the prerequisites to perform R&D abroad, 
i.e. self-select into the sample of international R&D performing firms. 
The samples in 2006 and 2009 consist of 5187 and 7662 firms, respectively. Though the 
surveys are designed as a panel, merging the two cross-sections leads to a reduction of about 
50% in the amount of observations since participation is voluntary. For estimation purposes 
we further exclude firms with incomplete data for any of the relevant variables. 2118 firms 
remain for the empirical analysis.  
3.2 Dependent Variables 
We define two sets of dependent variables, following the approach many other studies have 
used to analyse the effect of firms’ national R&D activities on innovation success (see e.g. 
Griffith et al., 2006; Parisi et al., 2006). That is, we first investigate whether a firm has 
introduced new products in the period 2006 to 2008. According to the Oslo Manual, these 
new products could be either new to the market (market novelties) or new to the firm only 
(firm novelties), i.e. they greatly differ in their degree of novelty. We suppose that foreign 
R&D is more crucial for developing market novelties. Thus, we additionally differentiate 
between two binary variables, namely market novelties and firm novelties. 
Given that the firm has introduced a product innovation, market and firm novelty, 
respectively, we investigate the market success with these innovation outcomes in a similar 
manner as it has been done by a variety of studies before (Criscuolo and Haskel, 2003; 
Mairesse and Mohnen, 2005; Jefferson et al., 2006). In contrast to these studies that define 
innovation success by the share of sales in a given year due to innovations in the prior three 
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years, we employ a dynamic success measure that accounts for sales changes as proposed by 
Harrison et al. (2008). Innovation success is measured by the sales growth rate between the 
years 2006 and 2008 due to new products, market novelties and firm novelties introduced in 
this period of time, respectively. It is computed as the share of sales due to new products in 
2008 times sales in 2008 divided by sales in 2006. Table 1 summarizes the definition of the 
six dependent variables. 
Table 1: Definition of Dependent Variables 
Dependent Variables Definition 
Firms with product innovations 1 if the firm has introduced product innovations in the period 2006-2008. 
Product innovations are new or significantly improved products and/or 
services with respect to technological characteristics or intended uses. 
They could be either new to the market or to the firm only (market or 
firm novelties).  
Firms with market novelties 1 if the firm has launched market novelties in 2006-2008. Market 
novelties are product innovations that a firm has introduced onto the 
market prior to any competitor. 
Firms with firm novelties 1 if the firm has introduced at least one product in 2006-2008 that has 
been new to the enterprise but not to the market.  
Sales growth due to new products Growth rate of turnover between  2006-2008 due to new products in that 
period; computed as: share of sales with new products * (sales in 2008 / 
sales in 2006)  
Sales growth due to market novelties Growth rate of turnover between 2006-2008 due to market novelties in 
that period; computed as: share of sales with market novelties * (sales in 
2008 / sales in 2006)  
Sales growth due to firm novelties Growth rate of turnover between 2006-2008 due to firm novelties in that 
period; computed as: share of sales with firm novelties * (sales in 2008 / 
sales in 2006) 
 
3.3 Explanatory Variables 
The literature on innovation performance has identified the following main factors that 
influence innovation output: (i) firms’ actual innovation effort, (ii) technological capabilities 
describing the degree of technological accumulation and efficiency in the innovative search 
process, (iii) absorptive capacities, and (iv) the use of external knowledge.3 In this regard, the 
importance of continuous internal R&D activities as an indicator for innovative capabilities 
and absorptive capacities has been emphasised by many scholars. Becker and Peters (2000) 
for instance have shown that firms with pronounced absorptive capacities are more likely to 
have higher sales with new products. 
                                                 
3 For an overview see for instance Peters (2008) and Hall and Mairesse (2006) and the references cited therein. 
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Domestic and Foreign R&D Activities 
Our study is aimed at comparing the effect of domestic and foreign R&D on firms’ future 
innovation outcome and market success with innovations. We first construct two binary 
variables indicating German firms that solely perform R&D activities in Germany in 2005 
(firms with domestic R&D only) and that have both R&D laboratories in Germany and abroad 
(firms with domestic and foreign R&D).4 Note that differences between the effect of domestic 
and foreign R&D on innovation performance might capture differences in the access to 
external knowledge as well as differences in innovative capabilities and absorptive capacities 
that are built in the course of R&D activities. Furthermore, note that not all firms have 
performed R&D activities in 2005. Among the non-R&D performing firms we further 
separate between firms with no innovations activities (firms without innovation activities) and 
firms with innovation activities but without conducting any R&D activities (innovative firms 
without R&D). The latter group reflects the well-known fact that R&D is not the only way for 
an enterprise to introduce new products.5 The reference category in our analysis comprises 
innovative firms without R&D activities in 2005. 
In a second step, we further subdivide international R&D performers according to their degree 
of R&D internationalisation. We create three binary variables indicating the intensity of 
firms’ foreign R&D engagement by using the number of countries in which the firms carry 
out R&D activities. A firm is defined to have centralised, medium decentralised and 
decentralised foreign R&D activities if it performs R&D in one, two to three and more than 
three foreign countries, respectively. A detailed list of variable definitions is provided in 
Table 2.  
Control Variables 
In addition to dummies indicating the location of R&D activities, we include R&D intensity 
(R&D expenditure per sales in 2005) and non-R&D innovation intensity (innovation 
expenditure (except R&D expenditure) per sales in 2005) to capture innovation efforts. We 
expect the impact on innovation performance to be positive. We model a second order 
polynomial to account for any non-linearities. In addition to R&D, technological capabilities 
are measured by the share of high skilled employees in 2005 (Lööf and Heshmati, 2002).  
                                                 
4 Only one firm in the sample reported to perform R&D activities solely abroad. We therefore decided to exclude 
this firm from the estimation. Thus, we are not able to test the complementarity hypothesis. 
5 Other innovation activities include for instance the acquisition of machines and external knowledge such as 
patents and licenses. 
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Table 2: Definition of Explanatory Variables  
Innovation activities in year 2005 Definition 
Firms with domestic R&D only 1 if the firm performs intramural R&D activities only in Germany in 
2005 
Firms with domestic and foreign R&D 1 if the firm performs intramural R&D activities in Germany and in at 
least one R&D laboratory abroad  
Firms without R&D (reference group) 1 if the firm is engaged in other innovation activities except for 
intramural R&D activities in 2005, e.g. extramural R&D activities, 
acquisition of external knowledge or machines, design, product testing 
and preparation.  
Firms without innovation activities 1 if the firm is not engaged in any innovation activities in year 2005 
Firms with centralised foreign R&D 1 if the firm has an R&D lab in only 1 country abroad in year 2005 
Firms with medium decentralised 
foreign R&D 
1 if the firm has R&D labs in 2 or 3 countries abroad in year 2005 
Firms with decentralised foreign R&D 1 if the firm has R&D labs in 4 or more countries abroad  in year 2005
Control Variables related to year 2005 Definition 
R&D intensity R&D expenditure per sales in year 2005 
Non-R&D-intensity Innovation expenditure (except for R&D) per sales  in year 2005 
High-skilled employees No. of graduated employees per total number of employees  in year 
2005 
Degree of product diversification 1 divided by the share of sales with the most important product  in year 
2005 
National group 1 if the firm is part of a national group 
Intern. group with German HQ 1 if the firm is part of an international group headquartered in Germany
Intern. group with HQ abroad 1 if the firm is part of an international group headquartered abroad 
Exporter 1 if the firm is exporting to markets abroad in year 2005 
Firm size No. of employees in year 2005 (in log) 
Firm in East Germany 1 if the firm is located in East Germany 
Competitive Environment   
Competition: Price Average importance of price as indicator of competition (at NACE 3 
industry level)  
Competition: Technology Average importance of technological advantage as indicator of 
competition (at NACE 3 industry level)  
Industry Industry classification is based on Legler and Frietsch (2007) 
High R&D-intensive manufacturing 1 if the firm belongs to high R&D intensive manufacturing (NACE 3 
digit: 233, 242, 244, 296, 300, 321-323, 331-333, 353) 
Medium R&D-intensive manufacturing 1 if the firm belongs to medium R&D intensive manufacturing (NACE 
3 digit: 241, 246, 251, 291, 293-295, 311, 312, 314-316, 334, 341, 343, 
352) 
Low R&D-intensive manufacturing 1 if the firm belongs to low R&D intensive manufacturing (NACE 3 
digit: 150-455, except for those industries already counted as high and 
medium R&D intensive manufacturing)  
Knowledge-intensive services 1 if the firm belongs to the knowledge-intensive service sectors 
(NACE 3 digit: 221, 523, 603, 611, 622, 623, 643, 651, 652, 660, 671, 
701, 721-726, 731, 732, 741-744, 921-925) 
Other services (reference group) 1 if the firm belongs to other service sectors (not counted as 
knowledge-intensive service sector)  
 
Besides proxies for innovation effort, technological capabilities, absorptive capacity and use 
of external knowledge, we control for the effect of a variety of additional variables. We 
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include firm size (number of employees in 2005, in log.), firm location (dummy variable that 
is 1 if the firm is located in East Germany) as well as the ownership structure of the firms. 
That is, we distinguish whether the firm is a single entity (reference category), part of a 
national group, part of an international group with a German headquarter or an international 
group with headquarter abroad.  
Nelson (1959) stressed that more diversified firms possess more opportunities for exploiting 
new knowledge and complementarities among their diversified activities (economies of scope 
in innovation) and therefore tend to be more innovative. The degree of product diversification 
might also indicate the level of firm knowledge and skills (Vermeulen and Barkema, 2002). It 
has been found to have an impact on firm performance (Chatterjee and Wernerfelt, 1991) and 
innovation success (Crepon et al. 1998). We include degree of product diversity in our 
estimations that is measured by 1 divided by the share of sales with the most important 
product in 2005. We furthermore include three variables that characterise the competitive 
environment of firms: two variables that measure whether the competition is rather price or 
technology driven (average importance of price and technology advantage as competitive 
factor, measured at the industry level, i.e. NACE 3 digit level) and a dummy variable that 
equals one if the firm serves international markets in 2005 (exporter). Finally, we define five 
industry dummies: firms belonging to high R&D-intensive manufacturing, medium R&D-
intensive manufacturing, low R&D-intensive manufacturing, knowledge-intensive services 
and other services (reference category). The categorisation of industries has been done 
following the method of Legler and Frietsch (2007) for the Federal Ministry of Education and 
Research to distinguish industries by their level of R&D intensity and knowledge intensity. 
3.3 Descriptive Statistics 
After merging the 2006 and 2009 survey via the identification number of firms we retrieve a 
sample of 2118 innovation active firms in Germany. The descriptive statistics in Table 5 in 
the annex section demonstrates that R&D activities are still predominately concentrated in the 
national innovation environment. 28% of the sample firms conducted R&D activities solely in 
their home country in 2005. 11% of the firms performed R&D activities in both Germany and 
foreign countries. About half of them (5%) preferred to focus their R&D work in one foreign 
country. Two or three foreign countries as sources in their innovation network are used by 3% 
of our sample firms and 2% of the firms are characterised by decentralised R&D activities, 
i.e. they had R&D labs in more than three countries. 19% of firms undertook innovation 
activities without doing R&D in 2005 while 42% of firms had no innovation activities.  
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Regarding innovation outcome, about 39% of the sample firms have introduced new products 
in the period between 2006 and 2008, of which 21% launched market novelties and 34% 
reported firm novelties. The average sales growth between 2006 and 2008 that is due to new 
products is about 13%. 3% sales growth can be attributed to market novelties whereas firm 
novelties account for on average 10% sales growth in our sample. The average firm size in 
our sample is 4.278 which corresponds to 2488 employees. 18% of the firms are domestic 
groups. Multinational firms with headquarters in Germany comprise about 13% of the sample 
firms while 7% are headquartered abroad. The following graphs illustrate the innovation 
outcome and innovation success by firms’ R&D efforts and the geographic location of R&D 
activities. Consistently across all three types of product innovations, firms with international 
R&D activities show a higher innovation outcome and given the introduction of a new 
product they are also more successful on the market with these products compared to firms 
with domestic R&D, firms with innovations but no own R&D and firms without any 
innovation efforts in 2005. This is particularly evident for firm novelties, less so for market 
novelties. Since these differences might also capture the effect of other firm-level variables or 
industry effects, we carry out an econometric analysis. 
Figure 1: Innovation Outcome and Innovation Success by R&D Location 
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Notes: Innovation outcome is measured as the share of firm that have introduced an innovation. Innovation 
success is measured as the average sales growth rate due to each type of product innovation. 
3.5 Estimation Method 
To test our hypotheses we estimate three knowledge production functions (Griliches, 1986), 
one for each type of innovation (product innovation, market novelties, firm novelties). Since 
market success with innovations can only be observed if the firm has introduced an 
innovation, we carry out the two-step estimation procedure proposed by Heckman (1976, 
1979). The selection equation estimates the effects of the explanatory variables on the 
likelihood to launch innovations (innovation outcome). Given the introduction of an 
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innovation, the second step of the Heckman estimation is designed to estimate the impact of 
the explanatory variables on the growth of sales due to this innovation outcome (structural 
equation).  
Firm size and the degree of product diversification serve as exclusion restriction. That is, we 
include them in the selection equation but exclude them from the structural equation. This 
partial overlap of the explanatory variables in the selection and structural equation ensures 
that the identification of parameters does not solely rely on functional form assumptions. The 
validity of these exclusion restrictions cannot be formally tested (see Wooldridge, 2005). 
However, they seemed to be justified since when including the full set of variables in both 
equations the two variables are significant in the selection equation but have no significant 
effects in the structural equation (see Table 8 and Table 7 for results of marginal effects).6  
4 Empirical Results  
Table 3 and Table 4 present the main estimation results that are the effect of international and 
national R&D locations as well as of different degrees of R&D internationalization on firms’ 
innovation outcome and innovation success. Columns 2, 4 and 6 of Tables 3 and 4 report 
marginal effects for a firm’s likelihood to generate product innovations, firm novelties and 
market novelties. Corresponding innovation success is explained in columns 3, 5 and 7. 
Figures show the marginal effect defined as conditional expectation.  
Table 10 and Table 11 in the annex section of the paper present a robustness check of the 
previous estimations by eliminating firms from the sample that belong to a group with 
headquarter abroad. 
Innovation Outcome of International R&D Activities  
The estimates show that the influence of international R&D locations is significantly positive 
on all innovation outcome measures. Domestic R&D activities turned out to be conducive to 
innovation outcome as well. On the other hand, firms without any innovation activities in the 
year 2005 are significantly less (negative) likely to develop and to introduce new products in 
the following period 2006-2008. Having said this, our prime intention was to compare firms 
with domestic versus international R&D activities. We thus statistically test on equality 
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between both effects. As can be gauged from the F-test, the effects of domestic R&D and 
R&D abroad are significantly different from each other. Firms with international R&D 
activities exhibit a significantly higher propensity to introduce product novelties, market 
novelties and firm novelties. The relative difference between the marginal effect of national 
and international R&D is greatest for market novelties, which is also reflected in the test 
statistics (significant at the 1% level (0.009)). The influence of international R&D activities 
on new product development and firm novelties is about one third larger than the effect of 
domestic R&D activities. Overall, the results strongly confirm our first hypothesis and thus 
the assumptions of the knowledge-based view that multiple locations offer firms attractive 
sources of knowledge. In addition, the results suggest that foreign subsidiaries are actually 
carrying out knowledge sourcing tasks and that foreign knowledge is successfully integrated 
into the innovation process of the whole firm.  
The empirical analysis further reveals intriguing results regarding the impact of the degree of 
R&D internationalisation on innovation outcomes (Table 6). On the one hand, it turns out that 
innovation outcome is positively related to the degree of R&D internationalisation. That is, 
the propensity to introduce products new to the market and new to the firm increases with the 
degree of decentralisation. Firms with medium decentralised foreign R&D activities have a 
significantly higher likelihood to develop both market and firm novelties compared to firms 
with only one foreign subsidiary (centralised foreign R&D). Comparing firms that have 
medium decentralised and decentralised foreign R&D activities, the results are not clear-cut. 
A more decentralised foreign R&D organization does not exert an additional stimulating 
effect on the propensity to develop market novelties. On the other hand, it further increases 
the likelihood to develop firm novelties. Actually, we could not retrieve marginal effects for 
the effect of firms with decentralised foreign R&D on the likelihood to generate new products 
and firm novelties. The underlying reason is that all firms in our sample that have a high 
degree of R&D internationalisation (R&D departments in more than three countries) have 
product innovations and firm novelties. The explanatory variable therefore predicts 
innovation outcome perfectly and the observations are dropped. These findings mainly 
support our hypothesis H3a in which we expected that innovation outcome increases with the 
degree of R&D internationalisation. Comparing our results with studies examining the effect 
of nationally dispersed R&D activities, we have to ascertain that our results contradict the 
                                                                                                                                                        
6 In this specification the parameters of the structural equation are identified because the inverse Mills ratio is a 
non-linear function of the variables included in the selection equation. However, the non-linearity of the inverse  
Mills ratio arises from the assumption of normality in the selection equation. 
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findings of Argyres and Silverman (2004) who found a U-shaped relationship. They are in 
line with Leiponen and Helfat (2010) who find that two domestic R&D locations are most 
beneficial to product and process innovations as well as to any kind of innovation. 
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Table 3: Effect of Domestic and International R&D on Innovation Outcome and 
Innovation Success 
  Product Innovation Market Novelties Firm Novelties 
  Yes/No Sales growth Yes/No Sales growth Yes/No Sales growth
Prior innovation activities in 2005 (ref.: 
firms with innovation act. except R&D)                 
Firms without innovation activities -0.200 *** -0.070 * -0.131 *** -0.027   -0.188 *** -0.077 ** 
  (0.021)  (0.037)   (0.024)  (0.020)   (0.023)  (0.031)   
Firms with domestic R&D only 0.115 *** 0.046 ** 0.079 *** 0.008   0.126 *** 0.046 ** 
  (0.022)  (0.023)   (0.019)  (0.013)   (0.022)  (0.022)   
Firms with domestic and foreign R&D 0.168 *** 0.069 ** 0.136 *** 0.005   0.186 *** 0.069 ***
  (0.035)   (0.028)   (0.026)   (0.017)   (0.034)   (0.026)   
Firm size 0.033 *** -   0.031 *** -   0.031 *** -   
  (0.005)    (0.004)    (0.005)    
Degree of diversification 0.024 *** -   0.008  -   0.003  -   
  (0.008)    (0.006)    (0.005)    
R&D intensity 0.525 *** 0.486 *** 0.388 *** 0.384 *** 0.310 * 0.185 * 
  (0.190)  (0.129)   (0.128)  (0.091)   (0.177)  (0.112)   
Non-R&D innov. intensity -0.018  0.038   0.091  0.141 *** 0.024  -0.115   
  (0.097)  (0.089)   (0.076)  (0.050)   (0.095)  (0.080)   
Share of high skilled employees 0.098 ** 0.064 * 0.132 *** 0.022   0.078 * 0.053   
  (0.044)  (0.038)   (0.038)  (0.019)   (0.045)  (0.034)   
Exporter 0.057 *** -0.001   0.062 *** -0.009   0.044 ** 0.012   
  (0.019)  (0.020)   (0.017)  (0.012)   (0.019)  (0.017)   
Firm in East Germany 0.003  0.012   -0.033 ** -0.019 ** 0.002  0.026 * 
  (0.018)  (0.017)   (0.017)  (0.009)   (0.018)  (0.017)   
Ownership (ref: unaffiliated firm)            
National group -0.004  0.027   -0.019  0.011   -0.006  0.023   
  (0.023)  (0.019)   (0.020)  (0.010)   (0.023)  (0.017)   
Internat. group, German HQ 0.054 * 0.032   0.026  0.011   0.052 * 0.031   
  (0.032)  (0.023)   (0.025)  (0.011)   (0.031)  (0.021)   
Internat. group, HQ abroad -0.047  0.030   -0.049 * 0.030 ** -0.085 ** 0.019   
  (0.034)  (0.026)   (0.027)  (0.013)   (0.034)  (0.025)   
Competition            
Price -0.050 * -0.026   -0.021  0.008   -0.070 *** -0.030 * 
  (0.026)  (0.020)   (0.021)  (0.010)   (0.026)  (0.018)   
Technology -0.007  0.022   -0.007  0.004   0.005  0.018   
  (0.015)  (0.014)   (0.013)  (0.007)   (0.015)  (0.013)   
Industries (ref: other services)            
High R&D-intensive manufacturing 0.127 *** -0.064   0.072 * -0.002   0.100 ** -0.064   
  (0.045)  (0.043)   (0.037)  (0.019)   (0.044)  (0.041)   
Medium R&D-intensive manufacturing 0.129 *** -0.017   0.083 ** 0.014   0.093 ** -0.028   
  (0.040)  (0.038)   (0.033)  (0.018)   (0.040)  (0.036)   
Low R&D-intensive manufacturing 0.058 ** 0.004   0.042 * 0.019   0.064 ** -0.013   
  (0.024)  (0.027)   (0.024)  (0.015)   (0.025)  (0.026)   
Knowledge-intensive services 0.044  -0.051   -0.004  -0.018   0.039  -0.036   
  (0.032)   (0.035)   (0.031)   (0.018)   (0.033)   (0.032)   
lambda   0.158    0.122 **   0.207   
     (0.120)      (0.062)       (0.137)   
W all 0.000 *** 0.000 *** 0.000 *** 0.000 *** 0.000 *** 0.009 ***
H0: dom. R&D≥ for. R&D 0.054 * 0.112   0.004 *** 0.594   0.022 ** 0.084 * 
N° of observations 2118    2118    2118    
censored obs. 1303    1666    1400    
uncensored obs. 815      452      718      
Notes: Marginal effects are reported. W_all is the test statistic of a Wald test on joint significance of all explanatory 
variables. H0: dom. R&D ≥ for. R&D tests the null hypothesis that domestic R&D activities have a larger or the same effect 
as foreign R&D activities. The p-value of the F-test is reported. 
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Another interesting result emerges when we compare firms with domestic R&D and 
internationally dispersed R&D activities. It turns out that firms with domestic R&D and 
centralised foreign R&D do not significantly differ in their propensity to develop new 
products, neither market novelties nor firm novelties. The prior finding that firms with foreign 
R&D activities benefit much more in terms of innovation outcome than domestic R&D 
performers is thus mainly driven by firms with medium or decentralised international R&D 
activities. The robustness check (in Table 10 and Table 11 in the annex section) of these 
results in which we run the same estimations but on a sample which does only include 
national firms approve all results for innovation outcomes of domestic and international 
innovating firms.  
Innovation Success of International R&D activities 
We secondly investigate the effect of international R&D activities on the innovation success 
measured by the sales growth due to new products, market novelties and firm novelties. 
Columns 3, 5 and 7 of Table 4 present average marginal effects for the expected value of the 
corresponding sales growth rates conditional on being selected. The estimates reveal that 
firms with international R&D activities exhibit higher product innovation success than firms 
without R&D. Compared to firms that solely perform domestic R&D, they also tend to 
achieve higher sales growth due to new products although the difference is not statistically 
significant (p-value of a one-sided test: 0.112). These overall results for product innovations 
are mainly driven by firm novelties. On the contrary, we cannot ascertain significant results 
regarding the innovation success with market novelties. Given the introduction of a market 
novelty, firms with international R&D activities do not outperform other firms. That is, once a 
firm has introduced a market novelty, the location of R&D activities does not matter for 
innovation success. Overall, these findings do not confirm our second hypothesis in which we 
anticipated that firms with international R&D activities will achieve higher innovation 
success than firms with only domestic R&D activities.  
Investigating the impact of different degrees of international R&D decentralisation on 
innovation success with new products, we find a strong non-linear effect. Firms with medium 
decentralised R&D abroad achieve a higher sales growth with new products than firms which 
conduct R&D at home only. The difference is statistically significant. Interestingly, they also 
outperform firms with highly decentralised R&D activities. Overall, medium decentralised 
international R&D turns out to be most beneficial. As before, this finding is mainly driven by 
firm novelties, not by market novelties. That is, given the introduction of a market novelty, 
the degree of decentralisation of international R&D activities does not play a role for 
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innovation success. In this vein, we neither can confirm our hypothesis H4a nor H4b. 
However, our results are in line with Leiponen and Helfat (2010). They find a positive 
significant impact for firms with two domestic R&D locations on the share of sales with 
product innovations. The results for prior non-innovative firms show a negative significant 
effect for the sales growth with firm novelties. 
In comparison with the innovation outcome estimations we obtain fewer significant results in 
our innovation success analysis. One possible explanation can be that much more departments 
than R&D alone are involved until innovations are ready for the market. However, as was put 
forward by Singh (2008), it might also well be that foreign R&D activities do not lead to a 
higher quality of innovations and therefore limit their market success. 
Foreign R&D of German subsidiary firms that belong to an international group with 
headquarter abroad might be quite different compared to foreign R&D of German firms with 
headquarter in Germany. However, the robustness check corroborates that the positive effects 
of (domestic and) international R&D activities is not driven by the former group of firms. 
Overall, the robustness estimates show a few less significant effects: the weak significance of 
domestic R&D on sales growth due to new products as well as the weak significant effect of 
centralised international R&D on sales growth due to firm novelties vanishes.  
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Table 4: Effect of Degree of Decentralization of International R&D on Innovation 
Outcome and Innovation Success  
  Product Innovation Market Novelties Firm Novelties 
  Yes/No Sales growth Yes/No Sales growth Yes/No Sales growth
Prior innovation activities in 2005 (ref.: firms with 
innovation activities except R&D)                    
Firms without innovation activitities -0.210 *** -0.065   -0.129 *** -0.027   -0.203 *** -0.078 ** 
  (0.021)  (0.040)   (0.024)  (0.021)   (0.022)  (0.033)   
Firms with domestic R&D only 0.100 *** 0.042 * 0.079 *** 0.007   0.102 *** 0.041 ** 
  (0.022)  (0.023)   (0.019)  (0.013)   (0.022)  (0.021)   
Firms with centralised foreign R&D 0.093 ** 0.051   0.092 *** 0.004   0.097 ** 0.049 * 
  (0.041)  (0.032)   (0.030)  (0.018)   (0.039)  (0.029)   
Firms with medium decent. foreign R&D 0.352 *** 0.125 *** 0.196 *** 0.013   0.277 *** 0.112 ***
  (0.107)  (0.036)   (0.043)  (0.020)   (0.072)  (0.032)   
Firms with  decentralised foreign R&D -  0.036   0.189 *** -0.010   -  0.038   
     (0.043)   (0.059)   (0.025)       (0.036)   
Firm size 0.034 *** -   0.030 *** -   0.033 *** -   
  (0.005)    (0.004)    (0.005)    
Degree of diversification 0.024 *** -   0.008  -   0.003  -   
  (0.008)    (0.006)    (0.005)    
R&D intensity 0.664 *** 0.496 *** 0.387 *** 0.397 *** 0.472 *** 0.192 * 
  (0.193)  (0.133)   (0.129)  (0.099)   (0.178)  (0.116)   
Non-R&D innov. intensity -0.010  0.036   0.092  0.141 *** 0.033  -0.120   
  (0.097)  (0.092)   (0.075)  (0.052)   (0.095)  (0.082)   
Share of high skilled emp 0.105 ** 0.060   0.137 *** 0.024   0.086 * 0.050   
  (0.045)  (0.040)   (0.038)  (0.020)   (0.045)  (0.035)   
Exporter 0.060 *** -0.001   0.062 *** -0.009   0.048 ** 0.014   
  (0.019)  (0.021)   (0.017)  (0.013)   (0.020)  (0.018)   
Firm in East Germany -0.001  0.015   -0.035 ** -0.019 ** -0.001  0.028   
  (0.018)  (0.018)   (0.016)  (0.010)   (0.019)  (0.017)   
Ownership (ref: unaffiliated firm)            
National group -0.003  0.028   -0.018  0.012   -0.006  0.025   
  (0.023)  (0.020)   (0.020)  (0.010)   (0.023)  (0.017)   
Internat. group, German HQ 0.053  0.025   0.019  0.012   0.053 * 0.027   
  (0.032)  (0.025)   (0.025)  (0.012)   (0.032)  (0.022)   
Internat. group, HQ abroad -0.046  0.028   -0.050 * 0.029 ** -0.080 ** 0.018   
  (0.034)  (0.027)   (0.027)  (0.014)   (0.035)  (0.025)   
Competition            
Price -0.046 * -0.019   -0.018  0.010   -0.063 ** -0.024   
  (0.026)  (0.021)   (0.021)  (0.011)   (0.026)  (0.018)   
Technology -0.008  0.022   -0.005  0.004   0.004  0.019   
  (0.016)  (0.015)   (0.013)  (0.007)   (0.016)  (0.013)   
Industries (ref: other services)            
High R&D-intensive manufacturing 0.130 *** -0.061   0.063 * -0.000   0.108 ** -0.060   
  (0.045)  (0.045)   (0.037)  (0.020)   (0.045)  (0.042)   
Medium R&D-intensive manufacturing 0.130 *** -0.020   0.069 ** 0.014   0.106 *** -0.028   
  (0.040)  (0.040)   (0.034)  (0.018)   (0.040)  (0.038)   
Low R&D-intensive manufacturing 0.061 ** 0.003   0.041 * 0.021   0.070 *** -0.013   
  (0.024)  (0.028)   (0.024)  (0.015)   (0.025)  (0.027)   
Knowledge-intensive services 0.047  -0.045   -0.003  -0.017   0.043  -0.028   
  (0.033)   (0.037)   (0.031)   (0.019)   (0.034)   (0.033)   
lambda   0.131    0.122 *   0.195   
     (0.119)      (0.065)       (0.131)   
W all 0.000 *** 0.000 *** 0.000 *** 0.000 *** 0.000 *** 0.016 **
H0: dom. R&D>=cent. for. R&D 0.578  0.373   0.298  0.577   0.548  0.372   
H0: dom. R&D>=med.decent. for. R&D 0.009 *** 0.004 *** 0.002 *** 0.321   0.007 *** 0.004 ***
H0: dom. R&D>=decent. for. R&D -  0.566   0.027 ** 0.807   -  0.542   
H0: cent.for.R&D>=med.decent.for.R&D 0.010 *** 0.017 ** 0.010 *** 0.276   0.009 *** 0.017 ** 
H0: decent. for.R&D>=med.decent.for.R&D -  0.021 ** 0.460  0.102   -  0.021 ** 
H0: cent.for.R&D>=decent.for.R&D -   0.636   0.055 * 0.776   -   0.618   
N° of observations 2086    2086    2086    
censored obs. 1298    1659    1393    
uncensored obs. 788      427      693      
Notes: See Table 3.  
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Estimation Results of Control Variables 
Overall, the estimates highlight the stimulating role of innovative capabilities for innovation 
outcome. Both firms’ R&D intensity and share of high skilled employees increase the 
likelihood of developing firm and market novelties. With respect to R&D intensity, we find a 
non-linear effect for all kinds of innovations.7 Interestingly, we do not find a significant 
impact of non-R&D innovation intensity on innovation outcome. Firms that have a higher 
degree of product diversification are furthermore more likely to introduce new products. Past 
export activities turn out to be conducive to future innovation activities as we find significant 
effects for all kinds of product innovation. The ownership of firms shows varying results. We 
do not find any significant differences between unaffiliated firms, national groups and firms 
belong to a multinational group with headquarter in Germany. On the contrary, international 
firms which are headquartered abroad are less likely to introduce firm and market novelties. 
Regarding the competitive environment, we find a negative effect of price competition on the 
introduction of firm novelties and product innovations, but no impact of technology 
competition on innovation.  
Innovation success is driven by the firms’ R&D and non-R&D innovation intensity (in case of 
market novelties). The results further indicate that firms belonging to a multinational group 
with headquarter abroad achieve higher innovation success with market novelties than other 
firms. Firm location, in our estimations defined as whether the firm is located in the eastern 
part of Germany, has an ambiguous effect. On the one hand, firms located in East Germany 
are less likely to introduce market novelties and they benefit less in terms of innovation 
success. On the other hand, they outperform West German firms regarding the sales growth 
due to firm novelties. Firms that operate their businesses in a competitive environment that is 
characterised by price competition develop not only less firm novelties they also achieve a 
lower sales growth rate with these new products. 
5 Conclusions 
Central objective of this paper was to examine whether international R&D activities are 
conducive to innovation performance. We investigated whether firms with R&D activities 
outside their home country benefit from these ventures in terms of a better innovation 
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outcome and higher innovation success. We furthermore analysed how the degree of R&D 
internationalisation, in terms of the decentralisation into various countries, moderates firms’ 
innovativeness and innovation success. To show the benefits of a strategy to disperse R&D 
across foreign countries, we compared the estimation outcomes with the results of firms that 
solely perform R&D within the borders of their home country and non-R&D performing 
firms. Against the background of the trend to expand R&D facilities globally, our results are 
useful for firms to decide whether to internationalise their R&D activities at all as well as to 
extend their existing overseas R&D locations. The literature review of this study has revealed 
that the few existing studies have maybe answered the question of international R&D benefits 
insufficiently by relying only on patent data. This paper contributes to the literature by adding 
information about innovation outcomes that would not be captured by patent data, such as 
firm novelties and overall product innovations, as well as probably a certain share of market 
novelties. Moreover, we have also related the added value of international R&D activities to 
the market success with innovations. 
Our results show that firms that follow the trend and internationalise R&D activities have a 
great potential to strengthen their innovation performance. Firms with international R&D 
have a higher probability to develop product, market and firm novelties in comparison to 
firms that perform only domestic R&D or non-R&D performers. However, regarding the 
innovation success, the results are not as clear-cut. Given the introduction of a firm novelty, 
firms with international R&D centres are also more successful than non-R&D performers and 
tend to be more successful than firms conducting domestic R&D. On the contrary, the 
findings highlight that the location of R&D does not matter for the success of market 
novelties once the market novelty has been launched to the market.  
In our analysis, we also investigate how the number of locations affects innovation outcome 
and innovation success. The econometric results disclose an inverse u-shaped relationship. 
That is, a moderate number of R&D locations abroad is the most beneficial strategy for 
generating innovation outcomes (product innovations, market and firm novelties). The same 
conclusion can be drawn for the sales growth due to new products and firm novelties. Another 
salient finding originates from this analysis: Firms that have expanded their R&D only to one 
foreign country do not outperform firms with domestic R&D. Admittedly, we cannot say 
whether this is a general picture or whether this is due the fact that many of these firms might 
                                                                                                                                                        
7 Table 3 and 4 only reports the marginal effect of R&D intensity that is calculated based on the estimates of the 
linear and squared term of R&D intensity. The original coefficient estimates are provided in Table 9 in the 
appendix. 
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have just recently started to internationalise their R&D and are therefore still in a learning 
phase. This question is put on the agenda for future research.  
To sum up, international R&D seems to ease the access to new knowledge which evidently 
results in a higher probability of developing innovations and therefore contributes to firms’ 
competitiveness. Due to a lack of data, we cannot observe how knowledge is transferred and 
integrated within a multinational firm across countries. But based on our findings, we can 
conclude that on average firms with international R&D activities have successfully installed 
knowledge transfer methods to channel foreign knowledge from global subsidiaries back to 
the home country. Our results also emphasise the perspective that international R&D 
activities seem to complement existing research efforts. However, for the decision to set up 
R&D facilities at foreign subsidiaries, managers should carefully choose the specific locations 
and limit the number to a moderate extent. 
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7 Appendix 
Table 5: Descriptive Statistics 
No. Dependent and Explanatory Variables  Mean Std.Dev. Min Max 
  Firms with product innovations 0.385 0.487 0 1 
  Firms with market novelties 0.213 0.410 0 1 
  Firms with firm novelties 0.339 0.473 0 1 
  Sales growth due to new products 0.127 0.338 0 7.292 
  Sales growth due to market novelties 0.026 0.125 0 4.228 
  Sales growth due to firm novelties 0.101 0.288 0 6.946 
  Innovator without R&D (reference group) 0.188 0.391 0 1 
1 Firms with innovation activities 0.427 0.495 0 1 
2 Firms with domestic R&D only 0.276 0.447 0 1 
3 Firms with domestic and foreign R&D 0.111 0.314 0 1 
4 Firms with centralised foreign R&D 0.051 0.221 0 1 
5 Firms with medium decentralised foreign R&D 0.030 0.171 0 1 
6 Firms with decentralised foreign R&D 0.016 0.125 0 1 
7 Firm size 4.278 2.220 0 12.121 
8 Degree of product diversification 1.668 1.496 1 50 
9 High-skilled employees 0.195 0.232 0 1 
10 Exporter 0.492 0.500 0 1 
  National firm, unaffiliated (reference group) 0.621 0.485 0 1 
11 National group 0.179 0.384 0 1 
12 International group with German HQ 0.132 0.338 0 1 
13 International group with HQ abroad 0.068 0.251 0 1 
14 R&D intensity 0.027 0.116 0 2.667 
15 Non-R&D intensity 0.026 0.086 0 1.534 
16 Firm in East Germany 0.349 0.477 0 1 
17 Competition: Price 5.122 0.400 3.286 6 
18 Competition: Technology 3.283 0.710 1 5 
19 Industry: High R&D-intensive manufacturing 0.068 0.253 0 1 
20 Industry: Medium R&D-intensive manufacturing 0.108 0.310 0 1 
21 Industry: Low R&D-intensive manufacturing 0.405 0.491 0 1 
22 Industry: Knowledge-intensive services 0.197 0.398 0 1 
  Industry: Low R&D-intensive services (ref. group) 0.222 0.416 0 1 
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Table 6: Correlation matrix of explanatory variables (by No., see previous table)  
No. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
1 1.000
2 -0.427 1.000
3 -0.120 0.260 1.000
4 -0.088 0.192 0.178 1.000
5 -0.288 0.642 0.070 0.086 1.000
6 -0.225 0.487 0.181 0.189 0.272 1.000
7 -0.165 0.357 0.052 0.080 0.049 0.064 1.000
8 -0.128 0.277 0.161 0.224 0.210 0.262 0.079 1.000
9 -0.365 0.806 0.055 0.062 0.777 0.581 0.320 0.187 1.000
10 -0.154 0.464 0.449 0.294 0.020 0.028 0.202 0.262 -0.018 1.000
11 0.009 0.044 0.014 -0.017 0.037 -0.016 0.027 -0.047 0.024 0.049 1.000
12 -0.003 0.101 0.029 -0.004 0.092 0.031 -0.013 0.008 0.115 0.011 -0.198 1.000
13 0.062 0.072 0.033 0.013 0.048 0.052 0.020 0.019 0.070 0.026 -0.069 -0.038 1.000
14 0.079 0.278 0.094 0.069 0.201 0.223 0.086 0.104 0.267 0.123 0.076 0.172 -0.026 1.000
15 -0.015 0.284 0.089 0.107 0.233 0.295 0.083 0.100 0.292 0.045 0.233 0.204 -0.236 0.301 1.000
16 -0.057 0.042 0.032 0.013 0.031 0.063 0.019 0.021 0.035 0.020 0.028 -0.013 -0.172 0.064 0.216 1.000
17 0.652 0.176 0.061 0.056 0.131 0.143 0.068 0.090 0.168 0.053 -0.067 0.120 0.207 0.329 -0.011 -0.112 1.000
18 0.065 -0.102 -0.020 -0.025 -0.093 -0.078 0.001 -0.028 -0.098 -0.001 -0.035 -0.090 0.187 -0.152 -0.244 -0.238 0.038 1.000
19 0.059 0.079 0.025 0.077 0.073 0.091 0.028 0.062 0.084 0.021 -0.039 0.068 0.076 0.147 0.034 -0.054 0.315 0.001 1.000
20 0.051 0.160 0.037 0.041 0.111 0.126 0.039 0.080 0.141 0.058 0.012 0.100 -0.068 0.318 0.135 0.036 0.422 -0.033 -0.147 1.000
21 0.067 -0.095 -0.027 -0.050 -0.074 -0.086 -0.002 -0.046 -0.083 -0.024 0.036 -0.003 -0.340 -0.004 -0.003 0.010 -0.220 -0.005 -0.285 -0.339 1.000
22 -0.039 -0.017 -0.021 -0.010 -0.019 -0.028 -0.026 -0.027 -0.019 -0.027 -0.062 -0.078 0.513 -0.223 -0.148 -0.022 -0.069 0.003 -0.186 -0.221 -0.430 1.000
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Table 7: Results of Heckman estimation (No exclusion restrictions) – domestic and R&D 
abroad: Marginal effects 
  Product Innovation Market Novelties Firm Novelties 
  Yes/No Sales growth Yes/No Sales growth Yes/No Sales growth
Prior innovation activities in 2005 (ref.: 
firms with innov. activities except R&D)                  
Firms without innovation activitities -0.200 *** -0.083 ** -0.131 *** 0.020   -0.188 *** -0.106 ***
  (0.021)  (0.040)   (0.024)  (0.082)   (0.023)  (0.024)   
Firms with domestic R&D only 0.115 *** 0.051 ** 0.079 *** -0.025   0.126 *** 0.061 ***
  (0.022)  (0.022)   (0.019)  (0.051)   (0.022)  (0.017)   
Firms with domestic and foreign R&D 0.168 *** 0.071 *** 0.136 *** -0.043   0.186 *** 0.081 ***
  (0.035)   (0.026)   (0.026)   (0.071)   (0.034)   (0.020)   
Firm size 0.033 *** 0.003   0.031 *** -0.014   0.031 *** 0.007 * 
  (0.005)  (0.006)   (0.004)  (0.017)   (0.005)  (0.004)   
Degree of diversification 0.024 *** 0.001   0.008  -0.003   0.003  0.002   
  (0.008)  (0.003)   (0.006)  (0.004)   (0.005)  (0.004)   
R&D intensity 0.525 *** 0.464 *** 0.388 *** 0.683 *** 0.310 * 0.178 ** 
  (0.190)  (0.124)   (0.128)  (0.263)   (0.177)  (0.091)   
Non-R&D innov. intensity -0.018  0.033   0.091  0.258 ** 0.024  -0.075   
  (0.097)  (0.081)   (0.076)  (0.131)   (0.095)  (0.065)   
Share of high skilled employees 0.098 ** 0.066 * 0.132 *** -0.013   0.078 * 0.056 ** 
  (0.044)  (0.035)   (0.038)  (0.064)   (0.045)  (0.027)   
Exporter 0.057 *** 0.004   0.062 *** -0.050   0.044 ** 0.018   
  (0.019)  (0.020)   (0.017)  (0.054)   (0.019)  (0.013)   
Firm in East Germany 0.003  0.012   -0.033 ** -0.026   0.002  0.021   
  (0.018)  (0.016)   (0.017)  (0.019)   (0.018)  (0.013)   
Ownership (ref: unaffiliated firm)             
National group -0.004  0.023   -0.019  0.030   -0.006  0.014   
  (0.023)  (0.019)   (0.020)  (0.027)   (0.023)  (0.015)   
Internat. group, German HQ 0.054 * 0.027   0.026  0.019   0.052 * 0.023   
  (0.032)  (0.023)   (0.025)  (0.025)   (0.031)  (0.018)   
Internat. group, HQ abroad -0.047  0.022   -0.049 * 0.083   -0.085 ** -0.005   
  (0.034)  (0.028)   (0.027)  (0.060)   (0.034)  (0.024)   
Competition             
Price -0.050 * -0.026   -0.021  0.023   -0.070 *** -0.033 ** 
  (0.026)  (0.018)   (0.021)  (0.026)   (0.026)  (0.014)   
Technology -0.007  0.020   -0.007  0.010   0.005  0.013   
  (0.015)  (0.013)   (0.013)  (0.015)   (0.015)  (0.010)   
Industries (ref.: other services)             
High R&D-intensive manufacturing 0.127 *** -0.049   0.072 * -0.035   0.100 ** -0.022   
  (0.045)  (0.047)   (0.037)  (0.057)   (0.044)  (0.037)   
Medium R&D-intensive manufacturing 0.129 *** -0.007   0.083 ** -0.005   0.093 ** 0.000   
  (0.040)  (0.039)   (0.033)  (0.047)   (0.040)  (0.030)   
Low R&D-intensive manufacturing 0.058 ** 0.009   0.042 * 0.018   0.064 ** 0.007   
  (0.024)  (0.026)   (0.024)  (0.031)   (0.025)  (0.021)   
Knowledge-intensive services 0.044  -0.041   -0.004  -0.040   0.039  -0.013   
  (0.032)   (0.036)   (0.031)   (0.042)   (0.033)   (0.026)   
lambda   0.241     -0.063     0.536 * 
     (0.201)      (0.144)       (0.289)   
W_all 0.000 *** 0.000 *** 0.000 *** 0.000 *** 0.000 *** 0.080 * 
H0: dom. R&D >= for. R&D 0.054 * 0.135   0.004 *** 0.747   0.022 ** 0.078 * 
N° of observations 2118   2118   2118   2118   2118   2118   
censored obs. 1303    1666    1400    
uncensored obs. 815      452      718      
Notes: See Table 3. 
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Table 8: Results of Heckman estimation (No exclusion restrictions) – domestic R&D and 
degree of international R&D decentralisation: Marginal effects  
  Product Innovation Market Novelties Firm Novelties 
  Yes/No Sales growth Yes/No Sales growth Yes/No Sales growth 
Prior innovation activities in 2005 (ref.: firms 
with innovation activities except R&D)                    
Firms without innovation activitities -0.210 *** -0.057   -0.129 *** 0.012   -0.203 *** -0.095 *** 
  (0.021)  (0.057)   (0.024)  (0.078)   (0.022)  (0.032)   
Firms with domestic R&D only 0.100 *** 0.040   0.079 *** -0.021   0.102 *** 0.047 *** 
  (0.022)  (0.027)   (0.019)  (0.050)   (0.022)  (0.018)   
Firms with centralised foreign R&D 0.093 ** 0.050   0.092 *** -0.026   0.097 ** 0.050 ** 
  (0.041)  (0.034)   (0.030)  (0.058)   (0.039)  (0.024)   
Firms with medium decent. foreign R&D 0.352 *** 0.126 *** 0.196 *** -0.032   0.277 *** 0.111 *** 
  (0.107)  (0.038)   (0.043)  (0.079)   (0.072)  (0.028)   
Firms with  decentralised foreign R&D 0.000  0.039   0.189 *** -0.067   0.000  0.031   
  -   (0.047)   (0.059)   (0.092)   -   (0.031)   
Firm size 0.034 *** -0.002   0.030 *** -0.012   0.033 *** 0.004   
  (0.005)  (0.008)   (0.004)  (0.016)   (0.005)  (0.006)   
Degree of diversification 0.024 *** -0.000   0.008  -0.003   0.003  0.003   
  (0.008)  (0.004)   (0.006)  (0.004)   (0.005)  (0.004)   
R&D intensity 0.664 *** 0.502 *** 0.387 *** 0.670 ** 0.472 *** 0.201 ** 
  (0.193)  (0.141)   (0.129)  (0.299)   (0.178)  (0.100)   
Non-R&D innov. intensity -0.010  0.038   0.092  0.246 * 0.033  -0.093   
  (0.097)  (0.097)   (0.075)  (0.140)   (0.095)  (0.077)   
Share of high skilled emp 0.105 ** 0.058   0.137 *** -0.007   0.086 * 0.053 * 
  (0.045)  (0.043)   (0.038)  (0.064)   (0.045)  (0.030)   
Exporter 0.060 *** -0.004   0.062 *** -0.045   0.048 ** 0.017   
  (0.019)  (0.026)   (0.017)  (0.054)   (0.020)  (0.015)   
Firm in East Germany -0.001  0.015   -0.035 ** -0.025   -0.001  0.024   
  (0.018)  (0.019)   (0.016)  (0.019)   (0.019)  (0.016)   
Ownership (ref: unaffiliated firm)            
National group -0.003  0.031   -0.018  0.028   -0.006  0.019   
  (0.023)  (0.023)   (0.020)  (0.027)   (0.023)  (0.017)   
Internat. group, German HQ 0.053  0.027   0.019  0.022   0.053 * 0.023   
  (0.032)  (0.027)   (0.025)  (0.025)   (0.032)  (0.020)   
Internat. group, HQ abroad -0.046  0.033   -0.050 * 0.075   -0.080 ** 0.005   
  (0.034)  (0.034)   (0.027)  (0.061)   (0.035)  (0.028)   
Competition            
Price -0.046 * -0.019   -0.018  0.025   -0.063 ** -0.025   
  (0.026)  (0.022)   (0.021)  (0.027)   (0.026)  (0.016)   
Technology -0.008  0.023   -0.005  0.009   0.004  0.015   
  (0.016)  (0.016)   (0.013)  (0.015)   (0.016)  (0.012)   
Industries (ref.: other services)            
High R&D-intensive manufacturing 0.130 *** -0.070   0.063 * -0.023   0.108 ** -0.035   
  (0.045)  (0.060)   (0.037)  (0.051)   (0.045)  (0.047)   
Medium R&D-intensive manufacturing 0.130 *** -0.026   0.069 ** 0.003   0.106 *** -0.010   
  (0.040)  (0.050)   (0.034)  (0.042)   (0.040)  (0.038)   
Low R&D-intensive manufacturing 0.061 ** -0.000   0.041 * 0.023   0.070 *** -0.000   
  (0.024)  (0.033)   (0.024)  (0.029)   (0.025)  (0.027)   
Knowledge-intensive services 0.047  -0.051   -0.003  -0.034   0.043  -0.016   
  (0.033)   (0.045)   (0.031)   (0.041)   (0.034)   (0.031)   
lambda   0.095    -0.044     0.356   
     (0.201)      (0.153)       (0.284)   
W all 0.000 *** 0.000 *** 0.000 *** 0.000 *** 0.000 *** 0.064 *
H0: dom. R&D>=cent. for. R&D 0.578  0.358   0.298  0.595   0.548  0.437   
H0: dom. R&D>=med.decent. for. R&D 0.009 *** 0.007 *** 0.002 *** 0.614   0.007 *** 0.006 *** 
H0: dom. R&D>=decent. for. R&D -  0.515   0.027 ** 0.818   -  0.694   
H0: cent.for.R&D>=med.decent.for.R&D 0.010 * 0.020 ** 0.010 * 0.561   0.009 *** 0.013   
H0: decent. for.R&D>=med.decent.for.R&D -  0.972   0.540  0.848   -  0.994   
H0: cent.for.R&D>=decent.for.R&D -   0.602   0.055 * 0.803   -   0.725   
N° of observations 2086  2086   2086  2086   2086  2086   
censored obs. 1298    1659    1393    
uncensored obs. 788      427      693      
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Table 9: Coefficients of non-linear variables from Heckman estimation with exclusion 
restriction 
  Product Innovation Market Novelties Firm Novelties 
  Yes/No Sales growth Yes/No   Sales growth Yes/No   Sales growth
R&D intensity 2.867 *** 1.228 *** 2.387 *** 1.409 *** 2.062 *** 0.532   
  (0.832)  (0.349)   (0.805)  (0.217)   (0.770)  (0.351)   
R&D intensity squared -2.241 *** -0.703 ** -1.835 ** -0.940 *** -1.853 *** -0.220   
  (0.750)   (0.328)   (0.735)   (0.198)   (0.714)   (0.326)   
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Table 10: Robustness check I: Marginal effects of Heckman estimations – domestic and 
foreign R&D, firms belonging to an international group headquartered abroad excluded 
from the sample 
  Product Innovation Market Novelties Firm Novelties 
  Yes/No Sales Yes/No Sales growth Yes/No Sales 
Prior innovation activities in 2005 (ref.: firms 
with innovation activities except R&D)                  
Firms without innovation activitities -0.192 *** -0.070 * -0.115 *** -0.021   -0.186 *** -0.077 **
  (0.022)  (0.039)   (0.024)  (0.022)   (0.023)  (0.033)   
Firms with domestic R&D only 0.121 *** 0.045 * 0.087 *** 0.009   0.127 *** 0.046 **
  (0.023)  (0.025)   (0.020)  (0.014)   (0.023)  (0.023)   
Firms with domestic and foreign R&D 0.195 *** 0.067 ** 0.155 *** 0.008   0.209 *** 0.070 **
  (0.039)   (0.031)   (0.027)   (0.019)   (0.037)   (0.029)   
Firm size 0.029 *** -   0.028 *** -   0.029 *** -   
  (0.006)    (0.004)    (0.005)    
Degree of diversification 0.023 *** -   0.006  -   0.002  -   
  (0.009)    (0.005)    (0.005)    
R&D intensity 0.542 *** 0.509 *** 0.362 *** 0.403 *** 0.320 * 0.188   
  (0.200)  (0.136)   (0.128)  (0.108)   (0.184)  (0.115)   
Non-R&D innov. intensity -0.053  0.023   0.082  0.146 *** -0.024  -0.118   
  (0.099)  (0.092)   (0.074)  (0.056)   (0.097)  (0.081)   
Share of high skilled employees 0.091 ** 0.060   0.110 *** 0.023   0.075 * 0.053   
  (0.045)  (0.040)   (0.038)  (0.020)   (0.045)  (0.036)   
Exporter 0.044 ** -0.007   0.058 *** -0.011   0.032  0.005   
  (0.020)  (0.021)   (0.017)  (0.014)   (0.020)  (0.018)   
Firm in East Germany 0.004  0.006   -0.030 * -0.023 ** 0.010  0.020   
  (0.018)  (0.018)   (0.017)  (0.010)   (0.019)  (0.016)   
Ownership (ref: unaffiliated firm)             
National group 0.002  0.026   -0.016  0.010   -0.003  0.022   
  (0.023)  (0.019)   (0.019)  (0.010)   (0.023)  (0.017)   
Internat. group, German HQ 0.063 ** 0.029   0.027  0.008   0.057 * 0.027   
  (0.032)  (0.024)   (0.024)  (0.012)   (0.032)  (0.022)   
Competition             
Price -0.054 ** -0.026   -0.030  0.011   -0.077 *** -0.033 * 
  (0.026)  (0.021)   (0.021)  (0.011)   (0.026)  (0.018)   
Technology -0.009  0.021   -0.004  0.001   0.007  0.019   
  (0.016)  (0.015)   (0.014)  (0.007)   (0.016)  (0.013)   
Industries (ref.: other services)             
High R&D-intensive manufacturing 0.101 ** -0.065   0.051  0.003   0.075  -0.066   
  (0.047)  (0.045)   (0.038)  (0.020)   (0.046)  (0.042)   
Medium R&D-intensive manufacturing 0.146 *** -0.016   0.087 *** 0.022   0.094 ** -0.031   
  (0.041)  (0.041)   (0.034)  (0.018)   (0.041)  (0.038)   
Low R&D-intensive manufacturing 0.055 ** 0.001   0.038  0.023   0.057 ** -0.018   
  (0.024)  (0.028)   (0.024)  (0.016)   (0.025)  (0.027)   
Knowledge-intensive services 0.047  -0.054   -0.005  -0.014   0.032  -0.043   
  (0.033)   (0.038)   (0.031)   (0.019)   (0.034)   (0.034)   
lambda 0.108    0.121 *   0.191    
  (0.132)      (0.070)      (0.150)      
W_all 0.000 *** 0.000 *** 0.000 *** 0.000 *** 0.000 *** 0.032 **
H0: dom. R&D >= for. R&D 0.020 **  0.140  0.001 *** 0.541   0.007 ***  0.099 *  
N° of observations 1975      1975      1975      
censored obs. 1230    1567    1317    
uncensored obs. 715      408      658      
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Table 11: Robustness check II: Marginal effects from Heckman estimations - domestic 
R&D and degree of international R&D decentralisation, firms belonging to an 
international group headquartered abroad excluded from the sample 
  Product Innovation Market Novelties Firm Novelties 
  Yes/No Sales growth Yes/No Sales growth Yes/No Sales growth
Prior innovation activities in 2005  (ref.: firms 
with innovation activities except R&D)                    
Firms without innovation activitities -0.202 *** -0.062   -0.114 *** -0.021   -0.199 *** -0.075 ** 
  (0.022)  (0.043)   (0.024)  (0.023)   (0.023)  (0.035)   
Firms with domestic R&D only 0.106 *** 0.040   0.085 *** 0.008   0.103 *** 0.041 * 
  (0.022)  (0.026)   (0.019)  (0.015)   (0.022)  (0.022)   
Firms with centralised foreign R&D 0.134 *** 0.044   0.114 *** 0.008   0.123 *** 0.047   
  (0.047)  (0.037)   (0.032)  (0.020)   (0.044)  (0.032)   
Firms with medium decent. foreign R&D 0.332 *** 0.125 *** 0.218 *** 0.016   0.294 *** 0.115 ***
  (0.111)  (0.040)   (0.047)  (0.022)   (0.084)  (0.035)   
Firms with  decentralised foreign R&D -  0.038   0.210 *** -0.008   -  0.044   
     (0.047)   (0.063)   (0.028)       (0.039)   
Firm size 0.030 *** -   0.027 *** -   0.031 *** -   
  (0.006)    (0.004)    (0.005)    
Degree of diversification 0.023 *** -   0.006  -   0.001  -   
  (0.009)    (0.005)    (0.005)    
R&D intensity 0.705 *** 0.523 *** 0.359 *** 0.417 *** 0.501 *** 0.193   
  (0.203)  (0.142)   (0.129)  (0.117)   (0.184)  (0.122)   
Non-R&D innov. intensity -0.049  0.023   0.080  0.146 ** -0.017  -0.124   
  (0.100)  (0.097)   (0.074)  (0.058)   (0.097)  (0.085)   
Share of high skilled emp 0.096 ** 0.057   0.115 *** 0.024   0.083 * 0.050   
  (0.046)  (0.042)   (0.038)  (0.021)   (0.046)  (0.037)   
Exporter 0.047 ** -0.007   0.059 *** -0.011   0.035 * 0.007   
  (0.020)  (0.023)   (0.017)  (0.015)   (0.020)  (0.019)   
Firm in East Germany 0.001  0.008   -0.031 * -0.023 ** 0.006  0.022   
  (0.019)  (0.019)   (0.016)  (0.011)   (0.019)  (0.017)   
Ownership (ref: unaffiliated firm)             
National group 0.003  0.027   -0.015  0.011   -0.002  0.023   
  (0.023)  (0.020)   (0.019)  (0.010)   (0.023)  (0.018)   
Internat. group, German HQ 0.065 ** 0.019   0.019  0.009   0.061 * 0.020   
  (0.032)  (0.028)   (0.024)  (0.012)   (0.032)  (0.025)   
Competition             
Price -0.051 * -0.021   -0.028  0.014   -0.072 *** -0.027   
  (0.027)  (0.022)   (0.021)  (0.012)   (0.027)  (0.019)   
Technology -0.009  0.023   -0.001  0.001   0.008  0.020   
  (0.016)  (0.016)   (0.014)  (0.007)   (0.016)  (0.014)   
Industries             
High R&D-intensive manufacturing 0.103 ** -0.065   0.039  0.006   0.079 * -0.064   
  (0.047)  (0.048)   (0.038)  (0.021)   (0.047)  (0.044)   
Medium R&D-intensive manufacturing 0.150 *** -0.024   0.075 ** 0.023   0.103 ** -0.034   
  (0.042)  (0.044)   (0.034)  (0.019)   (0.041)  (0.040)   
Low R&D-intensive manufacturing 0.057 ** -0.001   0.037  0.025   0.061 ** -0.020   
  (0.025)  (0.029)   (0.024)  (0.016)   (0.025)  (0.028)   
Knowledge-intensive services 0.049  -0.051   -0.004  -0.013   0.034  -0.036   
  (0.033)   (0.040)   (0.031)   (0.020)   (0.034)   (0.035)   
lambda 0.108    0.122 *   0.166    
  (0.132)      (0.074)      (0.142)      
W all 0.000 *** 0.000 *** 0.000 *** 0.000 *** 0.000 *** 0.058 *
H0: dom. R&D>=cent. for. R&D 0.261  0.436   0.148  0.492   0.311  0.405   
H0: dom. R&D>=med.decent. for. R&D 0.020 ** 0.007 *** 0.001 *** 0.299   0.010 * 0.006 ***
H0: dom. R&D>=decent. for. R&D   0.516   0.020 ** 0.784     0.471   
H0: cent.for.R&D>=med.decent.for.R&D 0.045 ** 0.021 ** 0.018 ** 0.314   0.028 ** 0.022 ** 
H0: decent. for.R&D>=med.decent.for.R&D   0.033 ** 0.454  0.106     0.036 ** 
H0: cent.for.R&D>=decent.for.R&D    0.553   0.068 * 0.795       0.532   
N° of observations 1945    1945    1945  1945   
censored obs. 1230    1560    1311    
uncensored obs. 715      385      634      
 
